Nitric oxide (NO) is a newly discovered gas that plays an important role in cell communication and host resistance to infection. The production of NO was examined in the sera of seven children infected with human immunodeficiency virus type 1 (HIV-1) and in the sera of 14 children who became seronegative for HIV-1 during the first year of life. In addition, we determined serum levels of various cytokines, such as interleukin (IL)-1P, tumor necrosis factor (TNF)-a, and gamma interferon (IFN-y), inasmuch as these cytokines are potent inducers of NO production. Production of NO, detected as circulating serum levels of nitrite, was measured with use of the Griess reagent. Serum levels of cytokines were determined by enzyme immunoassay. Increased serum levels of nitrite were observed in children with HIV-1 infection (0.4 ± 0.2 p,moVL; P = .013), and in those who became seronegative for HIV-1 during the first year of life (0.5 ± 0.3 p,moVL; P = .04). Furthermore, serum levels of IL-1P and TNF-a were significantly elevated in children with HIV-1 infection (37.5 ± 23.6 pg/mL and 91.2 ± 45.1 pg/mL, respectively). Prophylactic administration of intravenous immune globulin provoked a significant decrease of circulating levels of nitrite in children with HIV-1 infection. In conclusion, NO may playa role as a cytostatic or cytotoxic factor for invading microorganisms, and thus it is probably involved in limiting and/or eradicating infection.
Nitric oxide (NO) is a highly reactive radical formed from t-arginine by the reaction of an enzyme, nitric oxide synthase [1] . The products of this enzymatic pathway: are L-citrulline and the highly reactive and unstable NO, which decomposes into other nitrogen oxides, such as nitrite, nitrate, and the potent oxidizing agent peroxynitrite [2] . NO is produced in large quantities during host defense and immunologic .reactions. Because it has cytotoxic properties and is generated by activated macrophages, it is likely to have a role in specific immunity [3] . The production of NO is a major mechanism in murine systems for the control of many intracellular organisms, including Leishmania species [4] , Toxoplasma gondii [5] , and Mycobacterium tuberculosis [6] . However, NO also exerts microbiostatic and microbicidal effects against pathogens, including fungi, bacteria, and some viruses [7, 8] .
Inducible NO synthase is induced by several cytokines, including IFN-y, IL-I,B, and TNF-a, as well as by endotoxin [9, 10] . Induction of NO synthase results in the capacity to form much larger amounts ofNO than does activation of constitutive NO synthase, which is not activated by cytokines or endotoxin [11] . The present study was designed to determine serum levels of nitrite in pediatric patients with HIV-1 infection. In addition,
Patients and Methods
Study population. From January 1987 through July 1994, 21 children were born to HIV-I-infected mothers at our facility. The diagnosis of HIV-1 infection was based on the findings of ELISA and western blotting and confirmed by PCR and/or viral culture. Seven children were affected by AIDS (3 boys and 4 girls; mean age, 6.0 ± 2.8 years), and 14 children became seronegative for HIV-1 during the first year of life (7 boys and 7 girls; mean age, 3.3 ± 2.3 years). Mothers of uninfected children and of those with AIDS did not receive antiretroviral therapy during pregnancy and delivery. Children with AIDS suffered from recurrent bacterial infections (otitis, bronchitis, and pneumonia), pneumonia due to Pneumocystis carinii, and disseminated cytomegalovirus infection (Class P-2, subclasses DI and D2). For comparison, 10 healthy children (6 boys and 4 girls; mean age, 9.7 ± 3.3 years) were evaluated. All subjects were HIV-I-seronegative by ELISA.
Medical evaluations and laboratory assessments were performed at least every 6 months during the first 2 years of life for uninfected children and every 3 months for children with AIDS. Children with more advanced disease required more frequent medical evaluations. Prophylactic treatment with intravenous immune globulin (IVIG), at the dosage of 400 mg/ kg every 4 weeks, was given to all HIV-I-infected patients. Blood samples were collected from all children at their current age. Serum levels of nitrite were determined before and 1 hour after administration of IVIG. (n = 7)
Children seronegative for HIV-1
crease in serum levels ofnitrite in these patients was noted after prophylactic administration ofIVIG. In addition, a concomitant increase in levels of IL-1,B and TNF-O' in the sera of children with AIDS was observed. Retroviruses stimulate expression of immediate-early genes and inducible NO synthase, and retrovirus-induced NO production causes damage of adjacent, uninfected cells [12, 13] . In particular, HIV-l also stimulates NO production by human macrophages in vitro, and the level of NO is elevated in adult patients with AIDS. Pietraforte et al. [14] have demonstrated that recombinant gp 120 HIV-1 envelope glycoprotein increases production of NO by human monocyte-derived macrophages. In addition, we have recently reported on evidence of increased production of NO in the sera of adult patients with AIDS, especially those infected with opportunistic pathogens, including T. gondii, P. carinii, M. tuberculosis, and Mycobacterium avium [15] .
More recently, we have also demonstrated (in an in vitro study) that production of NO from peripheral blood mononuclear cells and polymorphonuclear leukocytes was increased in adult patients with AIDS, particularly those with opportunistic infections, including cerebral toxoplasmosis and disseminated mycobacterial infection [16] . Increased levels of nitrite were also observed in the sera of children who became seronegative for HIV-1 during the first year of life. The elevated serum levels ofnitrite in these subjects may be related to the transitory presence of viral proteins of HIV-1, which may have stimulated production of NO. Several cytokines, including IFN-y, IL-1,B, and TNF-O', induce production of NO via stimulation of NO Table 1 shows serum levels of IL-1,B, TNF-O', and IFN-y in six children with AIDS.
As shown, there was a significant elevation of serum levels of IL-l,B and TNF-O' in these patients. On the other hand, a nonsignificant increase in IFN-y levels was observed as well. Table 2 shows serum levels of nitrite in four children with AIDS who were treated prophylactically with IVIG. As shown, there was usually a significant decrease in serum levels of nitrite in these patients after prophylactic administration of IVIG.
Nitrite and cytokine assay. Levels of nitrite in the sera of our patients were determined by the Griess reaction, adapted to microwell plates. Briefly, samples were deproteinized by the addition of 100 I-lL of 35% sulfosalicylic acid to 500 I-lL of sample and then centrifuged at 10,000g for 15 minutes. Two hundred I-lL of supernatant, 300 I-lL of 5% acqueous NH 4Cl buffer, and 60 I-lL of 5% NaOH were combined for analysis. A standard curve was prepared with known concentrations of NaN0 2 • Treated samples (100 I-lL) and standard curve (100 I-lL) were placed in a flat-bottom 96-well plate. One hundred I-lL of Griess reagent (0.1% naphthylethilenediaminedihydrochloride, 1% sulfanilamide, and 5% phosphoric acid) was added to each well. Samples were incubated for 10 minutes at room temperature in the dark and underwent absorbance at 550 nm in an automatic microplate reader.
Serum samples were also tested for levels of IL-l,B, TNF-0', and IFN-y by EIA. IL-1,B and TNF-O' levels were determined by means of Quantikine (R and D Systems, Minneapolis), whereas the IFN-y level was determined by an ELISA based on the sandwich principle (Holland Biotechnology, Leiden, the Netherlands). Cytokine levels were determined with use of an average of duplicate values based on each standard curve. In this assay, minimum detectable levels were 12 pg/mL for IL-l,B, 7.5 pg/mL for TNF-O', and 20 pg/mL for IFN-y. Statistical analysis. Data are expressed herein as means and SDs. Differences were evaluated for significance with a nonparametric Mann-Whitney U test and Wilcoxon's signed rank test, when appropriate. Differences were considered significant at P < .05. The value of an undetectable level of each cytokine was regarded as 0 pg/mL for simplification of the analysis.
In this study we have shown evidence of increased circulating levels of nitrite in children with AIDS. A significant de- synthase [9, 10] . The elevation of levels ofIL-l,B, TNF-a, and (to a lesser extent) IFN-')' in our pediatric patients with AIDS may represent strong stimulation of NO production, although HIV-1 itself induces NO production from several cells, including monocytes/macrophages [14] . Finally, we have demonstrated that administration of IVIG to our patients caused a significant reduction in serum levels of nitrite. It has been demonstrated that IVIG therapy is beneficial for HIV-1-infected children in that it reduces the number of viral and bacterial infections [17] . Although data from several clinical trials suggest its effectiveness against many infections or immune-mediated disorders [18] , little is known about the mechanisms ofaction oflVIG [18, 19] . However, the decreased serum levels of nitrite, after administration of IVIG, may be correlated with an inhibitory effect of IVIG on production and release of NO from several types of cells, particularly monocytes/macrophages (which host HIV-1) and polymorphonuclear leukocytes. It should be noted that we have investigated a small number of patients with AIDS and that although these findings are interesting, study of a larger number of such patients is needed to confirm our data.
In conclusion, increasing evidence indicates that NO may play a part in acute and chronic inflammation and that it is therefore probably involved in limiting and!or eradicating infection. Although NO may playa role as a cytostatic or cytotoxic factor, not only for invading microorganisms but also for the cells that produce it and for neighboring cells, its potential role in immunity to HIV-1 infection warrants further investigations. in the late stages of AIDS. Therapy with high-dose oral acyclovir (800 mg five times a day) or iv acyclovir (10-12 mg t.i.d. for 7-14 days) can induce clearing of the lesions, but relapses occur frequently. Patients with AIDS are often given long-term maintenance therapy with oral acyclovir, but resistant virus (TK-) can emerge; in this case, treatment with foscamet is required [1] [2] [3] .
The skin lesions produced by acyclovir-resistant VZV are typically verrucous and hyperkeratotic, as is illustrated in our case (figure 1) [4] . The verrucous lesions evolved from small vesicular pustular papules to raised hyperkeratotic papules that were 2 em in diameter. Histologic examination of specimens from the lesions revealed multinucleated giant cells (figure 2), and VZV was cultured from the lesions. Serum IgG and IgM antibodies to VZV were not detected in our patient.
In cases of dissemination, VZV can cause ocular infection. In our case, acute retinal necrosis occurred following retinal artery occlusion that was secondary to VZV infection ( figure  3 ). In Spain, VZV is the fifth most common cause of infectious retinitis (after cytomegalovirus, Candida species, Mycobacterium species, and Toxoplasma gondii) in patients with AIDS [5] . VZV retinitis has also been reported by several investigators in the United States [6] [7] [8] .
The mild inflammatory response in the retina, aggressive systemiccourse, andfrequent bilateralism of the ocularlesions suggest the diagnosis of retinal VZV infection; the coexistence of VZV skin lesions is also helpful in makingthis diagnosis [8] . VZV can cause retinitis and the acute retinal necrosis syndrome after retinal artery occlusion has occurred [9] . Retinal detachments occur frequently in AIDS patients with VZV retinitis [6, 7] .
Our patient developed the acute retinal necrosis syndrome; this syndrome was associated with diffuse whitish retinal edema, macular hemorrhage, and blindness. He was treated with iv foscamet (40 mg/kg every 8 hours) and his skin lesions partially healed. He died of bacterial pneumonia 8 weeks after admission to the hospital.
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